摘要:
An organic luminescent device material which is a compound represented by the following formula (I): Formula (I) wherein V, W, X and Y each represents L1—NR1R2, wherein R1 and Rz each represents an aliphatic hydrocarbon group, an aryl group or a heterocyclic group, R1 and R2 may be combined directly or indirectly to form a ring, and L1 represents a divalent linking group containing an aryl group and/or an aromatic heterocyclic group.
摘要:
A photothermographic material comprising (a) a reducible silver source, (b) a photocatalyst, (c) a reducing agent, (d) a binder, and (e) a compound represented by the following formula (I): wherein Q represents an atomic group necessary to form a six-membered heterocycle containing two to four nitrogen atoms; Y represents --CO--, --SO--, or --SO.sub.2 --; X.sub.1 and X.sub.2 each represent a halogen atom; and A represents a hydrogen atom or an electron withdrawing group, the photothermographic material exhibiting low fogging without deterioration in image tone and sensitivity decrease.
摘要:
A photothermographic material contains a compound of formula (I): ##STR1## wherein X represents --N.dbd., --N(R)--, --O--or --S--wherein R represents hydrogen, hydroxy, aliphatic hydrocarbon, aryl or heterocyclic group, Z represents a valence bond or a group of non-metallic atoms necessary to form a 5 to 7-membered ring with X, and each of Q.sub.1 and Q.sub.2 represents a group of non-metallic atoms necessary to form an aromatic hydrocarbon ring or aromatic heterocycle fused to the ring completed by Z. The material has high sensitivity in the infrared region and a minimal sensitivity change with varying storage conditions.
摘要:
A medicament for treatment of cancer comprising a compound represented by the following general formula (I) or a physiologically acceptable salt thereof: Ar1—S—R1—S—Ar2 wherein R1 represents a nonmetal bridging group; Ar1 and Ar2 independently represent a group selected from the group consisting of an aryl group which has, on its ring, one to three hydroxyl groups optionally substituted with a monovalent group and said aryl group may have one to three substituents other than hydroxyl group on its ring; and a heteroaryl group which has, on its ring, one to three hydroxyl groups optionally substituted with a monovalent group, and said heteroaryl group may have one to three substituents other than hydroxyl group on its ring.
摘要翻译:一种用于治疗癌症的药物,其包含由以下通式(I)表示的化合物或其生理学上可接受的盐:其中R1表示非金属桥连基团; Ar 1和Ar 2独立地表示选自以下的基团:在其环上具有1〜3个任选被一价基团取代的羟基的芳基,所述芳基可以在其上具有1-3个除羟基以外的取代基 环; 和在其环上具有任选被一价基团取代的一至三个羟基的杂芳基,并且所述杂芳基可以在其环上具有一至三个除羟基以外的取代基。
摘要:
A polyhalomethane compound represented by the following formula and a silver halide photosensitive material containing the same are disclosed. ##STR1## (Q.sub.1 represents a 1,2,4-triazole ring, etc., Z.sub.1 and Z.sub.2 each represents a halogen atom, Y represents --SO.sub.2 --, etc., and A represents a halogen atom, etc.)The polyhalomethane compound is useful as a highly active antifoggant which enables photosensitive materials, especially of the heat development type, to have excellent raw-stock storage stability and image storage stability when stored in a stacked state, without reducing sensitivity nor impairing color tone.